BioPlus Co Ltd
KOSDAQ:099430
BioPlus Co Ltd
Total Assets
BioPlus Co Ltd
Total Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
BioPlus Co Ltd
KOSDAQ:099430
|
Total Assets
₩264.3B
|
CAGR 3-Years
44%
|
CAGR 5-Years
66%
|
CAGR 10-Years
N/A
|
|
|
Suheung Co Ltd
KRX:008490
|
Total Assets
₩1T
|
CAGR 3-Years
2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
6%
|
|
|
SD Biosensor Inc
KRX:137310
|
Total Assets
₩3.9T
|
CAGR 3-Years
9%
|
CAGR 5-Years
87%
|
CAGR 10-Years
N/A
|
|
|
H
|
HLB Inc
KOSDAQ:028300
|
Total Assets
₩703.5B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
1%
|
CAGR 10-Years
22%
|
|
|
T
|
T&L Co Ltd
KOSDAQ:340570
|
Total Assets
₩197.1B
|
CAGR 3-Years
26%
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
|
|
I
|
Interojo Co Ltd
KOSDAQ:119610
|
Total Assets
₩220.3B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
3%
|
CAGR 10-Years
10%
|
|
BioPlus Co Ltd
Glance View
BioPlus Co., Ltd. is engaged in the manufacturing and supplying of diverse dermal fillers. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2021-09-27. The firm is engaged in the production and sale of biomaterials for tissue restoration used for temporary improvement of facial wrinkles, namely hyaluronic acid fillers. In addition, the Company is engaged in the production and sale of anti-adhesion agents that reduce the formation of adhesions in surgical areas, biomaterials for joint tissue repair, and other products.
See Also
What is BioPlus Co Ltd's Total Assets?
Total Assets
264.3B
KRW
Based on the financial report for Dec 31, 2024, BioPlus Co Ltd's Total Assets amounts to 264.3B KRW.
What is BioPlus Co Ltd's Total Assets growth rate?
Total Assets CAGR 5Y
66%
Over the last year, the Total Assets growth was 53%. The average annual Total Assets growth rates for BioPlus Co Ltd have been 44% over the past three years , 66% over the past five years .
